Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301348 · ClinicalTrials.gov registry record · NA
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
A NA study of Thromboembolism, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05301348 is a NA study of Thromboembolism that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 30 participants, below the 312-participant average among 8 other Thromboembolism trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05301348, a NA study of Thromboembolism, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
Conditions Studied
Interventions
- DEVICE Photoacoustic Flow Cytometry
Study Locations (1)
Arkansas
- Univerisity of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05301348
The ClinicalTrials.gov registry entry for NCT05301348 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 312-participant average among 8 other Thromboembolism trials with a reported enrollment target (90% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Photoacoustic Flow Cytometry is the first listed.
NCT05301348 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT05301348 about?
NCT05301348 is a clinical study titled "In Vivo Detection of Circulating Clots in Patients With Thromboembolism". Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
What is the current status of trial NCT05301348?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-26. Estimated completion is 2027-01-31.
What conditions does trial NCT05301348 study?
This clinical trial studies the following conditions: Thromboembolism.
What interventions are being tested in trial NCT05301348?
The interventions under investigation include: Photoacoustic Flow Cytometry (DEVICE).
Who is sponsoring clinical trial NCT05301348?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301348 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
COMPLETED · NA
-
Strategies for Anticoagulation During Venovenous ECMO
COMPLETED · NA
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
COMPLETED · NA
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
ACTIVE NOT RECRUITING · Phase 4
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.